SUPPLEMENT

Q4 2025 — Financial statement information

Q4 2025PDF · 15 pages319 KB
Three months ended
December 31,
Year ended
December 31,
2025 2024 2025 2024
Net sales $ 6,133 $ 6,010 $ 24,948 $ 24,575
Operating expenses
Cost of sales 4,075 3,744 14,991 14,447
Selling, general and administrative expenses 965 899 3,997 4,221
Research, development and related expenses 299 282 1,169 1,085
(Gain) loss on business divestitures (2) — 162 —
Total operating expenses 5,337 4,925 20,319 19,753
Operating income 796 1,085 4,629 4,822
Other expense (income), net 38 326 416 3
Income from continuing operations before income taxes 758 759 4,213 4,819
Provision for income taxes 185 33 1,003 804
Income from continuing operations of consolidated group 573 726 3,210 4,015
Income from unconsolidated subsidiaries, net of taxes 1 2 52 9
Net income from continuing operations including noncontrolling interest 574 728 3,262 4,024
Less: net income (loss) attributable to noncontrolling interest (3) — 12 15
Net income from continuing operations attributable to 3M 577 728 3,250 4,009
Net income from discontinued operations, net of taxes — — — 164
Net income attributable to 3M $ 577 $ 728 $ 3,250 $ 4,173
Earnings per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic 534.3 543.6 537.4 550.8
Earnings per share from continuing operations — basic $ 1.08 $ 1.34 $ 6.05 $ 7.28
Earnings per share from discontinued operations — basic — — — 0.30
Earnings per share — basic $ 1.08 $ 1.34 $ 6.05 $ 7.58
Weighted average 3M common shares outstanding — diluted 539.0 546.3 541.3 552.4
Earnings per share from continuing operations — diluted $ 1.07 $ 1.33 $ 6.00 $ 7.26
Earnings per share from discontinued operations — diluted — — — 0.29
Earnings per share — diluted $ 1.07 $ 1.33 $ 6.00 $ 7.55
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per-share amounts)
(Unaudited)
1

-- 1 of 15 --

December 31, 2025 December 31, 2024
Assets
Current assets
Cash and cash equivalents $ 5,235 $ 5,600
Marketable securities 698 2,128
Accounts receivable – net 3,533 3,194
Inventories 3,661 3,698
Prepaids 391 493
Assets held for sale 46 —
Other current assets 2,823 771
Total current assets 16,387 15,884
Property, plant and equipment – net 7,101 7,388
Operating lease right of use assets 516 565
Goodwill and intangible assets – net 7,522 7,491
Other assets 6,207 8,540
Total assets $ 37,733 $ 39,868
Liabilities and equity
Current liabilities
Short-term borrowings and current portion of long-term debt $ 1,670 $ 1,919
Accounts payable 2,702 2,660
Accrued payroll 718 712
Operating lease liabilities 167 163
Liabilities held for sale 55 —
Other current liabilities 4,283 5,802
Total current liabilities 9,595 11,256
Long-term debt 10,932 11,125
Other liabilities 12,459 13,593
Total liabilities 32,986 35,974
Total equity 4,747 3,894
Shares outstanding
December 31, 2025: 530,279,131
December 31, 2024: 539,470,303
Total liabilities and equity $ 37,733 $ 39,868
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2

-- 2 of 15 --

Year ended December 31,
2025 2024
Net cash provided by (used in) operating activities $ 2,306 $ 1,819
Cash flows from investing activities:
Purchases of property, plant and equipment (910) (1,181)
Purchases and proceeds from sale or maturities of marketable securities and
investments – net 2,163 (2,079)
Other investing activities 97 54
Net cash provided by (used in) investing activities 1,350 (3,206)
Cash flows from financing activities:
Change in debt – net (716) 5,506
Purchases of treasury stock and dividends paid to shareholders (4,813) (3,783)
Proceeds from issuances of treasury stock pursuant to stock option and benefit plans 1,562 92
Cash transferred to Solventum related to separation, net — (621)
Other financing activities (49) (96)
Net cash provided by (used in) financing activities (4,016) 1,098
Effect of exchange rate changes on cash and cash equivalents 41 (44)
Net increase (decrease) in cash and cash equivalents, including cash classified within
assets held for sale (319) (333)
Less: net increase (decrease) in cash classified within assets held for sale 46 —
Net increase (decrease) in cash and cash equivalents (365) (333)
Cash and cash equivalents at beginning of year 5,600 5,933
Cash and cash equivalents at end of period $ 5,235 $ 5,600
The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash
and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of
discontinued operations in the 3M Consolidated Balance Sheet.
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3

-- 3 of 15 --

Three months ended December 31, 2025
By reportable business segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 3.8 % — % 2.2 % 6.0 %
Transportation and Electronics (2.5) (0.2) 1.0 (1.7)
Consumer (2.2) — 1.0 (1.2)
Total reportable business segments 0.4 (0.1) 1.6 1.9
Total Company 0.6 (0.1) 1.6 2.1
By geographic area
Americas 0.1 % (0.1) % 0.5 % 0.5 %
China (1.9) — 1.1 (0.8)
Other Asia 5.0 — (1.2) 3.8
Europe, Middle East and Africa (0.6) — 7.8 7.2
Year ended December 31, 2025
By reportable business segment Organic sales Divestitures Translation Total sales
change
Safety and Industrial 3.2 % — % 0.7 % 3.9 %
Transportation and Electronics (1.5) (0.1) 0.3 (1.3)
Consumer (0.3) — 0.1 (0.2)
Total reportable business segments 0.9 — 0.4 1.3
Total Company 0.9 0.2 0.4 1.5
By geographic area
Americas 1.3 % 0.3 % (0.3) % 1.3 %
China 4.3 0.1 0.1 4.5
Other Asia (0.1) — (0.6) (0.7)
Europe, Middle East and Africa (1.7) 0.2 3.9 2.4
2Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition
and divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months
post-transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS2
(Unaudited)
4

-- 4 of 15 --

3M discloses business segment operating income as its measure of segment profit, reconciled to both total 3M operating income
and income before taxes. Business segment operating income excludes certain expenses and income that are not allocated to
business segments (as described below in “Corporate and Other”).
Three months ended
December 31, Year ended
December 31,
Net sales (millions) 2025 2024 2025 2024
Abrasives $ 341 $ 320 $ 1,340 $ 1,295
Automotive Aftermarket 304 312 1,178 1,235
Electrical Markets 347 322 1,394 1,274
Industrial Adhesives and Tapes 568 513 2,266 2,104
Industrial Specialties Division 293 288 1,172 1,161
Personal Safety 917 829 3,544 3,371
Roofing Granules 95 119 490 521
Total Safety and Industrial business segment 2,865 2,703 11,384 10,961
Advanced Materials 187 218 858 969
Automotive and Aerospace 468 456 1,901 1,912
Commercial Branding and Transportation 606 587 2,602 2,528
Electronics 700 733 2,911 2,971
Total Transportation and Electronics business segment 1,961 1,994 8,272 8,380
Consumer Safety and Well-Being 260 249 1,108 1,080
Home and Auto Care 291 293 1,200 1,191
Home Improvement 369 371 1,486 1,486
Packaging and Expression 294 316 1,126 1,174
Total Consumer business segment 1,214 1,229 4,920 4,931
Total reportable business segments 6,040 5,926 24,576 24,272
Corporate and Other 93 84 372 303
Total company $ 6,133 $ 6,010 $ 24,948 $ 24,575
Operating income (millions)
Safety and Industrial $ 665 $ 572 $ 2,836 $ 2,491
Transportation and Electronics 140 233 1,436 1,578
Consumer 218 234 996 932
Total reportable business segments 1,023 1,039 5,268 5,001
Corporate and Other
Corporate-level (expense) income (14) (5) 75 (114)
Corporate special items:
Net costs for significant litigation (160) 51 (483) (45)
Divestiture costs — — — (20)
Gain (loss) on business divestitures 2 — (162) —
Transformation costs (55) — (69) —
Total Corporate and Other (227) 46 (639) (179)
Total company operating income 796 1,085 4,629 4,822
Other expense/(income), net 38 326 416 3
Income from continuing operations before income taxes $ 758 $ 759 $ 4,213 $ 4,819
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5

-- 5 of 15 --

Corporate and Other
Outside of 3M's reportable segments, 3M has Corporate and Other which is not a reportable business segment as it does not
meet the segment reporting criteria. Because Corporate and Other includes a variety of miscellaneous items, it is subject to
fluctuation on a quarterly and annual basis.
Corporate and Other operating income (loss) includes:
• Corporate-level (expense) income includes:
◦ certain enterprise and governance activities resulting in unallocated corporate costs and other activity or costs
that 3M may choose not to allocate directly to its business segments,
◦ commercial activity with Solventum following its April 1, 2024 Separation and certain operations of the
former Health Care business segment retained by 3M,
◦ transition arrangement agreements (e.g., fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to the Solventum Separation,
◦ operations of businesses of the former Health Care segment divested prior to the Separation and therefore not
reflected as discontinued operations within 3M's financial statements, along with limited-duration supply
agreements with previous divestitures, and
◦ costs previously allocated to Solventum prior to the Separation that were not eligible to be part of
discontinued operations.
• Corporate special items include, for the periods presented:
◦ net costs for significant litigation impacting operating income (loss) associated with PFAS-related other
environmental and Combat Arms Earplugs matters,
◦ gain (loss) on business divestitures,
◦ divestiture costs (related to separating and divesting substantially an entire business segment of 3M following
public announcement of its intended divestiture) that were not eligible to be part of discontinued operations,
and
◦ transformation program restructuring and related charges.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6

-- 6 of 15 --

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Other, except as described
with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of special items”
section. The reconciliations below, therefore, also include impacted segments as applicable.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful:
• Net sales (and sales change)
Considered, in addition to segment operating performance, in
evaluating and managing operations; useful in understanding
underlying business performance, provides additional transparency to
special items
• Operating income (loss), total reportable segment
operating income, segment operating income
(loss) and operating income (loss) margin (and
expansion)
• Income from continuing operations before taxes
• Provision for income taxes and effective tax rate
• Net income from continuing operations
• EPS from continuing operations
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
7

-- 7 of 15 --

Certain amounts adjusted for special items (non-GAAP measures):
Three months ended December 31, 2024
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Operating
income
Operating
income
margin
Income
before taxes
Provision for
income taxes Effective tax
rate
Net income
attributable
to 3M EPS
Safety and Industrial
GAAP amounts $ 572 21.2 %
Adjustments for special items:
Net costs for significant litigation (4)
Adjusted amounts (non-GAAP measures)3 $ 568 21.0 %
Transportation and Electronics
GAAP amounts $ 1,994 $ 233 11.7 %
Adjustments for special items:
Manufactured PFAS products (202) 114
Adjusted amounts (non-GAAP measures)3 $ 1,792 $ 347 19.4 %
Total reportable business segments
GAAP amounts $ 5,926 $ 1,039 17.5 %
Adjustments for special items:
Net costs for significant litigation — (4)
Manufactured PFAS products (202) 114
Adjusted amounts (non-GAAP measures)3 $ 5,724 $ 1,149 20.1 %
Total company
GAAP amounts $ 6,010 $ 1,085 18.1 % $ 759 $ 33 4.2 % $ 728 $ 1.33
Adjustments for special items:
Net costs for significant litigation — (55) 101 137 (36) (0.07)
Manufactured PFAS products (202) 114 114 27 87 0.16
Pension risk transfer charge — — 13 3 10 0.02
Solventum ownership - change in value — — 130 — 130 0.24
Total special items (202) 59 358 167 191 0.35
Adjusted amounts (non-GAAP measures)3 $ 5,808 $ 1,144 19.7 % $ 1,117 $ 200 17.9 % $ 919 $ 1.68
Three months ended December 31, 2025
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
Operating
income
margin
Operating
income
margin
expansion
Income
before
taxes
Provision
for
income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Safety and Industrial
GAAP amounts $ 665 23.2 %
Adjustments for special items:
Net costs for significant litigation 25
Adjusted amounts (non-GAAP measures)3 $ 690 24.1 %
Transportation and Electronics
GAAP amounts $ 1,961 (1.7) % $ 140 7.2 %
Adjustments for special items:
Manufactured PFAS products (110) 235
Adjusted amounts (non-GAAP measures)3 $ 1,851 3.3 % $ 375 20.3 %
Total reportable business segments
GAAP amounts $ 6,040 1.9 % $ 1,023 16.9 %
Adjustments for special items:
Net costs for significant litigation — 25
Manufactured PFAS products (110) 235
Adjusted amounts (non-GAAP measures)3 $ 5,930 3.6 % $ 1,283 21.6 %
Total company
GAAP amounts $ 6,133 2.1 % $ 796 13.0 % (510) bps $ 758 $ 185 24.5 % $ 577 $ 1.07 (20) %
Adjustments for special items:
Net costs for significant litigation — 185 310 10 300 0.56
Loss on business divestitures — (2) (2) — (2) —
Manufactured PFAS products (110) 235 235 22 213 0.39
Solventum ownership - change in value — — (160) — (160) (0.30)
Transformation costs — 55 55 (4) 59 0.11
Total special items (110) 473 438 28 410 0.76
Adjusted amounts (non-GAAP measures)3 $ 6,023 3.7 % $ 1,269 21.1 % 140 bps $ 1,196 $ 213 17.7 % $ 987 $ 1.83 9 %
3These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
8

-- 8 of 15 --

Year ended December 31, 2024
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Operating
income
Operating
income
margin
Income
before taxes
Provision for
income taxes Effective
tax rate
Net income
attributable
to 3M EPS
Safety and Industrial
GAAP amounts $ 2,491 22.7 %
Adjustments for special items:
Net costs for significant litigation 36
Adjusted amounts (non-GAAP measures)3 $ 2,527 23.1 %
Transportation and Electronics
GAAP amounts $ 8,380 $ 1,578 18.8 %
Adjustments for special items:
Manufactured PFAS products (945) 144
Adjusted amounts (non-GAAP measures)3 $ 7,435 $ 1,722 23.2 %
Total reportable business segments
GAAP amounts $ 24,272 $ 5,001 20.6 %
Adjustments for special items:
Net costs for significant litigation — 36
Manufactured PFAS products (945) 144
Adjusted amounts (non-GAAP measures)3 $ 23,327 $ 5,181 22.2 %
Total Company
GAAP amounts $ 24,575 $ 4,822 19.6 % $ 4,819 $ 804 16.7 % $ 4,009 $ 7.26
Adjustments for special items:
Net costs for significant litigation — 81 800 68 732 1.32
Divestiture costs — 20 20 (111) 131 0.24
Manufactured PFAS products (945) 144 144 34 110 0.20
Pension risk transfer charge — — 808 191 617 1.11
Solventum ownership - change in value — — (1,564) — (1,564) (2.83)
Total special items (945) 245 208 182 26 0.04
Adjusted amounts (non-GAAP measures)3 $ 23,630 $ 5,067 21.4 % $ 5,027 $ 986 19.6 % $ 4,035 $ 7.30
Year ended December 31, 2025
Amounts from continuing operations
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
Operating
income
margin
Operating
income
margin
expansion
Income
before
taxes
Provision
for income
taxes Effective
tax rate
Net income
attributable
to 3M EPS
EPS
percent
change
Safety and Industrial
GAAP amounts $ 2,836 24.9 %
Adjustments for special items:
Net costs for significant litigation 58
Adjusted amounts (non-GAAP measures)3 $ 2,894 25.4 %
Transportation and Electronics
GAAP amounts $ 8,272 (1.3) % $ 1,436 17.4 %
Adjustments for special items:
Manufactured PFAS products (669) 292
Adjusted amounts (non-GAAP measures)3 $ 7,603 2.3 % $ 1,728 22.7 %
Total reportable business segments
GAAP amounts $ 24,576 1.3 % $ 5,268 21.4 %
Adjustments for special items:
Net costs for significant litigation — 58
Manufactured PFAS products (669) 292
Adjusted amounts (non-GAAP measures)3 $ 23,907 2.5 % $ 5,618 23.5 %
Total Company
GAAP amounts $ 24,948 1.5 % $ 4,629 18.6 % (100) bps $ 4,213 $ 1,003 23.8 % $ 3,250 $ 6.00 (17) %
Adjustments for special items:
Net costs for significant litigation — 541 1,061 9 1,052 1.95
Loss on business divestitures — 162 162 3 159 0.29
Manufactured PFAS products (669) 292 292 36 256 0.47
Solventum ownership - change in value — — (402) 23 (425) (0.78)
Transformation costs — 69 69 (1) 70 0.13
Total special items (669) 1,064 1,182 70 1,112 2.06
Adjusted amounts (non-GAAP measures)3 $ 24,279 2.7 % $ 5,693 23.4 % 200 bps $ 5,395 $ 1,073 19.9 % $ 4,362 $ 8.06 10 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
9

-- 9 of 15 --

2026 forecast
2026 adjusted operating income margin expansion (non-GAAP measure)3,4 70 bps to 80 bps
2026 adjusted earnings per share from continuing operations (non-GAAP measure)3,4 $8.50 to $8.70
2026 adjusted effective tax rate (non-GAAP measure)3,4 ~20%
43M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or
provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant
litigation; projected divestiture gains (losses); divestiture costs; divestiture-related restructuring; changes in value of Solventum
ownership; transformation costs; and net sales and estimates of income and associated activity of exited manufactured PFAS products all
of which are subject to limitations in predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M
believes these limitations would result in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M
believes that the probable significance of such information is low. Additionally, for similar reasons, 3M does not include the impact of
potentially-divested or acquired businesses on expected operations in forecasted guidance it provides until close of a transaction.
Information with respect to special items for certain historical periods is included in the section entitled “Description of special items”.
Three months ended December 31, 2025
Sales change2 Organic sales Divestitures Translation Total sales
change
Total company 0.6 % (0.1) % 1.6 % 2.1 %
Remove manufactured PFAS products special item impact 1.6 — — 1.6
Adjusted total company (non-GAAP measures)3 2.2 % (0.1) % 1.6 % 3.7 %
Total reportable business segments 0.4 % (0.1) % 1.6 % 1.9 %
Remove manufactured PFAS products special item impact 1.6 — 0.1 1.7
Adjusted total reportable business segments (non-GAAP measures)3 2.0 % (0.1) % 1.7 % 3.6 %
Transportation and Electronics (2.5) % (0.2) % 1.0 % (1.7) %
Remove manufactured PFAS products special item impact 4.9 (0.1) 0.2 5.0
Adjusted Transportation and Electronics (non-GAAP measures)3 2.4 % (0.3) % 1.2 % 3.3 %
Six months ended June 30, 2025
Sales change2 Organic sales Divestitures Translation Total sales
change
Total Company 0.2 % 0.5 % (0.5) % 0.2 %
Remove manufactured PFAS products special item impact 1.3 — 0.1 1.4
Adjusted total Company (non-GAAP measures)3 1.5 % 0.5 % (0.4) % 1.6 %
Transportation and Electronics (2.8) % — % (0.2) % (3.0) %
Remove manufactured PFAS products special item impact 3.8 — — 3.8
Adjusted Transportation and Electronics (non-GAAP measures)3 1.0 % — % (0.2) % 0.8 %
Six months ended December 31, 2025
Sales change2 Organic sales Divestitures Translation Total sales
change
Total Company 1.6 % (0.1) % 1.3 % 2.8 %
Remove manufactured PFAS products special item impact 1.1 — — 1.1
Adjusted total Company (non-GAAP measures)3 2.7 % (0.1) % 1.3 % 3.9 %
Transportation and Electronics (0.3) % (0.2) % 1.0 % 0.5 %
Remove manufactured PFAS products special item impact 3.3 (0.1) — 3.2
Adjusted Transportation and Electronics (non-GAAP measures)3 3.0 % (0.3) % 1.0 % 3.7 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
10

-- 10 of 15 --

Year ended December 31, 2025
Sales change2 Organic sales Divestitures Translation Total sales
change
Total Company 0.9 % 0.2 % 0.4 % 1.5 %
Remove manufactured PFAS products special item impact 1.2 — — 1.2
Adjusted total Company (non-GAAP measures)3 2.1 % 0.2 % 0.4 % 2.7 %
Total reportable business segments 0.9 % — % 0.4 % 1.3 %
Remove manufactured PFAS products special item impact 1.2 (0.1) 0.1 1.2
Adjusted total reportable business segments (non-GAAP measures)3 2.1 % (0.1) % 0.5 % 2.5 %
Transportation and Electronics (1.5) % (0.1) % 0.3 % (1.3) %
Remove manufactured PFAS products special item impact 3.5 (0.1) 0.2 3.6
Adjusted Transportation and Electronics (non-GAAP measures)3 2.0 % (0.2) % 0.5 % 2.3 %
By geographic area
Americas 1.3 % 0.3 % (0.3) % 1.3 %
Remove manufactured PFAS products special item impact 0.4 — — 0.4
Adjusted Americas (non-GAAP measures)3 1.7 % 0.3 % (0.3) % 1.7 %
China 4.3 % 0.1 % 0.1 % 4.5 %
Remove manufactured PFAS products special item impact 0.5 — — 0.5
Adjusted China (non-GAAP measures)3 4.8 % 0.1 % 0.1 % 5.0 %
Other Asia (0.1) % — % (0.6) % (0.7) %
Remove manufactured PFAS products special item impact 3.2 — — 3.2
Adjusted Other Asia (non-GAAP measures)3 3.1 % — % (0.6) % 2.5 %
Europe, Middle East & Africa (1.7) % 0.2 % 3.9 % 2.4 %
Remove manufactured PFAS products special item impact 2.4 — 0.1 2.5
Adjusted Europe, Middle East & Africa (non-GAAP measures)3 0.7 % 0.2 % 4.0 % 4.9 %
By particular country
United States 1.0 % 0.4 % — % 1.4 %
Remove manufactured PFAS products special item impact 0.4 — — 0.4
Adjusted United States (non-GAAP measures)3 1.4 % 0.4 % — % 1.8 %
2026 forecast
Sales Change2 Organic sales Acquisitions Divestitures Translation Total sales change
Total Company4 ~3% — % — % ~1% ~4%
Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
December 31, Year ended
December 31,
Major GAAP cash flow categories (dollars in millions) 2025 2024 2025 2024
Net cash provided by (used in) operating activities $ 1,583 $ 1,818 $ 2,306 $ 1,819
Net cash provided by (used in) investing activities (405) (1,146) 1,350 (3,206)
Net cash provided by (used in) financing activities (617) (1,080) (4,016) 1,098
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
11

-- 11 of 15 --

Three months ended
December 31, Year ended
December 31,
Adjusted free cash flow (non-GAAP measure) (dollars in millions) 2025 2024 2025 2024
Net cash provided by (used in) operating activities $ 1,583 $ 1,818 $ 2,306 $ 1,819
Adjustments for special items:
Net costs/(recoveries) for significant litigation after-tax payment impacts 14 (192) 2,817 3,831
Divestiture costs and divestiture-related restructuring after-tax payment
impacts
17 44 102 374
TCJA transition tax payment — — 211 193
Transformation actions after-tax payment impacts 11 — 11 —
Manufactured PFAS products after-tax payment impacts (91) (63) (183) (229)
Total adjustments for special items (49) (211) 2,958 4,169
Adjusted net cash provided by (used in) operating activities (non-GAAP
measure)5
$ 1,534 $ 1,607 $ 5,264 $ 5,988
Purchases of property, plant and equipment (PPE) (248) (291) (910) (1,181)
Manufactured PFAS products impact - removing related purchases of PPE 5 17 20 70
Adjusted purchases of PPE (non-GAAP measure)5 $ (243) $ (274) $ (890) $ (1,111)
Adjusted free cash flow (non-GAAP measure)5 $ 1,291 $ 1,333 $ 4,374 $ 4,877
Net income attributable to 3M $ 577 $ 728 $ 3,250 $ 4,173
Adjustments for special items, net of tax:
Net costs for significant litigation 300 (36) 1,052 732
Manufactured PFAS products impact 213 87 256 110
Loss on business divestitures (2) — 159 —
Divestiture costs — — — 341
Solventum ownership - change in value (160) 130 (425) (1,564)
Pension risk transfer charge — 10 — 617
Transformation costs 59 — 70 —
Total adjustments for special items, net of tax 410 191 1,112 236
Net income attributable to 3M adjusted for special items
(used for adjusted free cash flow conversion calculation)
$ 987 $ 919 $ 4,362 $ 4,409
Adjusted free cash flow conversion (non-GAAP measure)5 131 % 145 % 100 % 111 %
53M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M
in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued
operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating
activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and
equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated
impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash
provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the
determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the
portion of payments of costs for significant litigation under the 2023 and 2025 settlement/proposed settlement agreements relative to Combat
Arms Earplugs and relative to public water suppliers and the state of New Jersey regarding PFAS is based on the timing/amount of the actual
cash tax deduction (which differs from the timing of the pre-tax cash settlement payments). The impacts of certain tax-related divestiture costs
are based on applicable tax rates and the timing of tax payments relative to underlying Separation transactions. For other special items, the
cash tax impact is estimated using the U.S. statutory corporate tax rate during the period of payment/receipt. Tax impacts include associated
impacts on Foreign Derived Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of
repatriation. 3M defines adjusted free cash flow conversion as adjusted free cash flow divided by net income attributable to 3M, adjusted for
special items (used for adjusted free cash flow conversion calculation).
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
12

-- 12 of 15 --

(Dollars in billions) 2026 forecast
Net cash provided by (used in) operating activities $5.6 to $5.8
Adjustments for special items4 —
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)4,5 $5.6 to $5.8
Purchase of property, plant and equipment (PPE) ~1.1
Adjusted free cash flow (non-GAAP measure)4,5 $4.6 to $4.8
Net income attributable to 3M $4.6 to $4.7
Adjustments for special items4 —
Adjusted net income attributable to 3M (non-GAAP measure)3,4 $4.6 to $4.7
Adjusted free cash flow conversion (non-GAAP measure)4,5 >100%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
13

-- 13 of 15 --

Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other
environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities
(including interest imputation on applicable settlement obligations), legal costs, and insurance recoveries, along with the
associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived Intangible
Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M does
not consider the elements of the net costs associated with these matters to be normal, operating expenses related to the
Company’s ongoing operations, revenue generating activities, business strategy, industry, and regulatory environment.
Net costs related to respirator mask/asbestos are reflected as special items in the Safety and Industrial business segment
while those impacting operating income (loss) associated with PFAS-related other environmental and Combat Arms
Earplugs matters are reflected as corporate special items in Corporate and Other. In the fourth quarter of 2025 and 2024,
3M reflected net pre-tax cash (receipts)/payments of $181 million and $(17.0) million, respectively, related to net costs for
significant litigation. In 2025 and 2024, 3M reflected net pre-tax cash (receipts)/payments of $3.5 billion and $4.5 billion,
respectively, related to net costs for significant litigation.
Loss on business divestitures:
• In 2025, 3M reflected a net write-down for a business classified as held for sale and completed a divestiture for immaterial
proceeds slightly below the business's book value.
Divestiture costs and divestiture-related restructuring actions:
• Divestiture costs include limited costs that were not eligible to be included within discontinued operations related to
separating and divesting substantially an entire business segment of 3M following public announcement of its intended
divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of updating
3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close
and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and discontinued
operations. Therefore, in the context of amounts used in the determination of non-GAAP measures associated with cash
flow and adjusted free cash flow conversion, this special item further includes the broader extent of such costs included
within discontinued operations, including interest expense on debt issued by Solventum for the period outstanding prior to
the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of entity structuring associated
with the separation of Solventum. In the fourth quarter and full year 2024, 3M made pre-tax cash payments of $28 million
and $245 million, respectively, associated with divestiture costs. Divestiture-related restructuring relates to actions
undertaken following the 2022 split-off of the Food Safety business to address corporate functional costs across 3M in
relation to the magnitude of amounts previously allocated to the divested business. In 2024, 3M made pre-tax cash
payments of $2 million associated with these actions.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA):
• In 2025 and 2024, 3M made payments of $211 million and $193 million, respectively, related to the transition tax expense
incurred as a result of the 2017 enactment of the TCJA.
Manufactured PFAS products:
• These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS
products that 3M exited by the end of 2025, included within the Transportation and Electronics business segment.
Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-
service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity of
manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of
associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated
payments.
Pension risk transfer charge:
• In 2024, 3M recorded a non-cash pension settlement charge reflected in other expense (income), net as a result of
transferring a portion of its U.S. pension payment obligations and related plan assets to an insurance company.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
14

-- 14 of 15 --

Solventum ownership - change in value:
• This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in
other expense (income), net.
Transformation costs:
• These represent net costs associated with 3M's transformation program, intended as a structural redesign of longer-term
manufacturing, distribution, and business process services and locations. Accordingly, 3M does not consider the nature or
effect of this program to be normal, operating expenses related to the Company’s ongoing operations, revenue generating
activities, and day-to-day business strategy. Net costs include restructuring and other related items such as site closure,
sale, moving and set-up, accelerated depreciation, and program management. In the fourth quarter and full year 2025, 3M
made pre-tax cash payments of $14 million associated with transformation costs.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
15

-- 15 of 15 --